4Kawasaki ET, Takino H, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease [J]. Diabetes, 1994,43:80-85. 被引量：1
5Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [J]. Diabetes Care, 1997,20(7):1183-1197. 被引量：1
6Scheen AJ, Castillo MJ, Lefebvre PJ. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test, methological aspects and clinical applications(Review) [J]. Diabetes Metabolism, 1996,22 : 397-406. 被引量：1
7Baekkeskov S, Aanstoot H J, Christgau S, et al. Identification of the 64-K autoantigen in insulin-dependent diabetes as the GADA-synthesizing enzyme glutamic acid decarbosxylase [J]. Nature,1990,347: 151-156. 被引量：1
8Greenbaum CJ, Sears KL, Kahn SE, et al. Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical type diabetes. Follow-up of the Seattle family study[J].Diabetes, 1999, 35:570-576. 被引量：1
9Ludvigsson J, Hellstrom S. Autoantibodies in relation to residual insulin secretion in children with IDDM [J]. Diabetes Res Clinical Pract, 1997, 35:81-89. 被引量：1
10Baekkeskov S, Nielsen JH, Marner B, et al. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature,1982, 298: 167. 被引量：1
